Parallels can be drawn between the outcomes of this study and two recently published studies (Poletti et al., 2024; Leboyer et al., 2024) in which low dose IL-2 (ld IL-2) was used in the treatment of unipolar and bipolar depressed patients. This evidence concerns the gene IL2 and depressive disorder.